Stock News

Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
Gilead's FOCUS Program Helps Zero In on Early HIV Detection
Gilead and Kite Oncology to Highlight Broad and Diverse Oncology Portfolio at ASCO 2024
Bargain Hunting: 7 Stocks Near 52-Week Lows to Buy Before the Bounce Back
23 Most Profitable Stocks of the Last 12 Months
Shhh! 3 Secret Biotech Stocks Flying Below Wall Street’s Radar
Gilead Sciences, Inc. (NASDAQ:GILD) Q1 2024 Earnings Call Transcript

As seen on...